Investment analysts at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock. OncoCyte Stock Performance OCX stock opened at $2.98 on Friday. OncoCyte has a one year low of $2.08 and a one year high […]
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the stock. OncoCyte Price Performance NASDAQ OCX opened at $3.02 on Monday. The company’s 50 day moving average is $3.05 and its 200-day moving average is $3.10. OncoCyte has a […]
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the stock. Several other research analysts also recently commented on OCX. Needham & Company LLC reduced their price objective on OncoCyte from $4.25 to $3.60 and set a buy rating […]
Stock analysts at StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock. A number of other equities analysts have also commented on the stock. Needham & Company LLC decreased their price target on shares of […]
Equities researchers at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the stock. A number of other equities analysts have also weighed in on OCX. Piper Sandler decreased their price target on shares […]